WELL Health Technologies (TSE:WELL – Free Report) had its price objective lifted by Raymond James from C$10.00 to C$11.00 in a research note released on Tuesday,BayStreet.CA reports.
Other research analysts have also recently issued reports about the company. Ventum Financial reduced their price target on WELL Health Technologies from C$8.00 to C$7.00 and set a “buy” rating for the company in a research report on Tuesday, October 29th. CIBC boosted their price objective on WELL Health Technologies from C$5.25 to C$7.00 in a report on Friday, December 13th. Scotiabank lifted their price objective on shares of WELL Health Technologies from C$6.00 to C$7.00 in a research note on Monday. Haywood Securities lifted their price objective on WELL Health Technologies from C$8.00 to C$10.00 in a report on Friday, December 13th. Finally, TD Securities raised their price target on WELL Health Technologies from C$8.00 to C$8.50 in a research report on Tuesday.
Read Our Latest Research Report on WELL Health Technologies
WELL Health Technologies Price Performance
WELL Health Technologies Company Profile
WELL Health Technologies Corp. operates as a practitioner-focused digital healthcare company in Canada, the United States, and internationally. It provides omni-channel patient services and solutions to specific markets, such as provider staffing, anesthesia, gastrointestinal health, women's health, primary care, and mental healthcare.
Featured Articles
- Five stocks we like better than WELL Health Technologies
- What is Short Interest? How to Use It
- AppLovin Insiders Sell Shares: Stock Price Indicated Higher
- Dividend Payout Ratio Calculator
- Broadcom’s Stellar Outlook Sparks Hopes for a Semi Sector Rally
- How to Use High Beta Stocks to Maximize Your Investing Profits
- Salesforce’s Clear Path to $400 and Beyond
Receive News & Ratings for WELL Health Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for WELL Health Technologies and related companies with MarketBeat.com's FREE daily email newsletter.